Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration

References

• Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the manage-ment of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34–45.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62: 2569–81.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69: 1580–8.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: rec-ommendations of an international task force. Ann Rheum Dis. 2010;69:631–7.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the man-agement of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010; 69:964–75.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Takeuchi T, Mimori T, Saito K, Nawata M, Kameda H, et al. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis. 2010;69:1286–91.
   PubMed Web of Science ®Google Scholar
• Klarenbeek NB, van der Kooij SM, Güler-Yüksel M, van Groenendael JH, Han KH, Kerstens PJ, et al. Discontinuing treatment in patients with rheumatoid arthritis in sustained clin-ical remission: exploratory analyses from the BeSt study. Ann Rheum Dis. 2011;70:315–9.
   Google Scholar
• Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009;61:772–8.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Fujikawa K, et al. Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheu-matoid arthritis. J Rheumatol. 2007;34:2154–7.
   PubMed Web of Science ®Google Scholar
• Tamai M, Kawakami A, Iwamoto N, Kawashiri SY, Fujikawa K, Aramaki T, et al. Comparative study of the detection of joint injury in early-stage rheumatoid arthritis by MRI of wrist and finger joints and physical examination. Arthritis Care Res. 2010 (in press).
   Google Scholar
• Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Na-kamura H, et al. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detec-tion of bone marrow oedema in early stage rheumatoid arthritis. Ann Rheum Dis. 2006;65:133–4.
   Google Scholar
• Tamai M, Kawakami A, Uetani M, Takao S, Rashid H, Tanaka F, et al. Early prediction of rheumatoid arthritis by serological variables and magnetic resonance imaging of the wrists and finger joints: results from prospective clinical examination. Ann Rheum Dis. 2006;65:134–5.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. The simplified disease activity index (SDAI) and clinical disease activity index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol. 2007;21:663–75.
   PubMed Web of Science ®Google Scholar
• Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nakajima A, et al. The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis. Mod Rheumatol. 2011;21:444–8.
   PubMed Web of Science ®Google Scholar
• Hodgson RJ, O'Connor P, Moots R. MRI of rheumatoid arthri-tis-image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology. 2008;47: 13–21.
   PubMed Web of Science ®Google Scholar
• Ostergaard M, Pedersen SJ, DOhn UM. Imaging in rheumatoid arthritis-status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography. Best Pract Res Clin Rheumatol. 2008;22:1019–44.
   Google Scholar
• Hetland ML, Ejbjerg B, Horsley-Petersen K, Jacobsen S, Vest-ergaard A, Junk AG, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheu-matoid arthritis. Results from a 2-year randomized controlled trial (CIMESTRA). Ann Rheum Dis. 2009;68: 384–90.
   Google Scholar
• Hetland ML, Stengaard-Pedersen K, Junker P, Ostergaard M, Ejbjerg BJ, Jacobsen S, et al. Radiographic progression and remission rates in early rheumatoid arthritis-MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis. 2010;69:1789–95.
   PubMed Web of Science ®Google Scholar
• Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, con-trolled trial. Arthritis Rheum. 2005;52:3381–90.
   Google Scholar
• van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Gfiler-Yiiksel M, Zwinderman AH, Kerstens PJ, et al. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis. 2009;68:914–21.
   PubMed Web of Science ®Google Scholar
• van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hu'smalls HM, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007;56: 1424–32.
   Google Scholar